India's Pharmaceutical Exports

Country Profile

Senegal

Senegal is a growing market for Indian pharmaceuticals — $92.6M in FY 2025–26, with 12.1× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $8.23M. The compound annual growth rate since FY2015 stands at 25.4%.

🇸🇳 $92.6M · 12.1× growth since FY2015 · 25.4% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$92.6M
Exports FY2025–26 DGCIS
12.1×
Growth FY2015→2026
25.4%
CAGR FY2015→2026
86%
Medicines Share
5
Product Categories Supplied
Senegal is a growing market for Indian pharmaceuticals — $92.6M in FY 2025–26, with 12.1× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $8.23M. The compound annual growth rate since FY2015 stands at 25.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $79.7M (86.0%) Vaccines $8.23M (8.9%) Medicine Ingredients $2.86M (3.1%) Surgical & Hospital Supplies $1.43M (1.5%) Traditional & Herbal $413K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Senegal in the RBI overseas direct investment dataset (2011–2026).